Immunologic aspects of blood transfusion

Area of Science:

• Transfusion Medicine
• Immunology
• Clinical Transplantation

Background:

• Clinical and laboratory studies over 20 years suggest allogeneic blood transfusions significantly impact recipient immune responses.
• Observations include improved renal allograft survival, but also decreased cancer survival and increased postoperative infection risk.
• Conflicting data also suggest benefits in conditions like Crohn's disease and recurrent abortion, hinting at immune tolerance induction.

Purpose of the Study:

• To review and synthesize the existing literature on the immunomodulatory effects of allogeneic blood transfusions.
• To explore the clinical relevance and controversial interpretations of transfusion-associated immune changes.
• To highlight the ongoing investigation into the mechanisms and clinical importance of these transfusion effects.

Main Methods:

• Review of clinical reports and laboratory observations spanning two decades.
• Analysis of studies on renal allograft survival, cancer patient outcomes, postoperative infections, and inflammatory conditions.
• Examination of laboratory findings on immune cell function and viral reactivation post-transfusion.

Main Results:

• Allogeneic transfusion is associated with improved renal allograft survival in some studies.
• Conversely, other studies link transfusions to decreased cancer survival and increased postoperative infection rates.
• Laboratory data show alterations in lymphocyte subsets, immune cell activity, and expression of latent viruses.

Conclusions:

• The immunomodulatory effects of allogeneic blood transfusion are complex and often contradictory.
• While some effects suggest immunosuppression or tolerance, others indicate potential adverse outcomes.
• Understanding the mechanisms and clinical significance remains a critical area of research in transfusion medicine.